Literature DB >> 25913000

Predictive value of programmed ventricular stimulation after catheter ablation of post-infarction ventricular tachycardia.

Miki Yokokawa1, Hyungjin Myra Kim1, Kazim Baser1, William Stevenson2, Koichi Nagashima2, Paolo Della Bella3, Pasquale Vergara3, Gerhard Hindricks4, Arash Arya4, Katja Zeppenfeld5, Marta de Riva Silva5, Emile G Daoud6, Sunil Kumar6, Karl-Heinz Kuck7, Ronald Tilz7, Shibu Mathew7, Hamid Ghanbari1, Rakesh Latchamsetty1, Fred Morady1, Frank M Bogun8.   

Abstract

BACKGROUND: A recent meta-analysis demonstrated a survival benefit in post-infarction patients whose ventricular tachycardia (VT) was rendered noninducible by catheter ablation. Furthermore, patients with noninducible VT had a lower VT recurrence rate than did patients whose VT remained inducible after ablation.
OBJECTIVES: The purpose of this multicenter cohort study was to assess whether noninducibility after VT ablation is independently associated with improved survival.
METHODS: Data from 1,064 patients who underwent VT ablation for post-infarction VT at seven international centers were analyzed. The ablation procedure was considered successful if no VT was inducible at the end of the procedure and unsuccessful if VT remained inducible or if programmed stimulation was not performed at the end of the ablation.
RESULTS: Median follow-up time was 633 days. Noninducibility was independently associated with lower mortality (adjusted hazard ratio: 0.65; 95% confidence interval: 0.53 to 0.79; p<0.001). Atrial fibrillation, diabetes, and age were other independent predictors of higher mortality. Ablation of only the clinical VT in patients who also had inducible, nonclinical VTs was not associated with improved survival.
CONCLUSIONS: Noninducibility after VT ablation in patients with post-infarction VT is independently associated with lower mortality during long-term follow-up.
Copyright © 2015 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ablation; mortality

Mesh:

Year:  2015        PMID: 25913000     DOI: 10.1016/j.jacc.2015.02.058

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  18 in total

1.  Advances in Cardiovascular Health in Women over the Past Decade: Guideline Recommendations for Practice.

Authors:  Pejman Raeisi-Giglou; Annabelle Santos Volgman; Hena Patel; Susan Campbell; Amparo Villablanca; Eileen Hsich
Journal:  J Womens Health (Larchmt)       Date:  2017-07-17       Impact factor: 2.681

2.  2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias.

Authors:  Edmond M Cronin; Frank M Bogun; Philippe Maury; Petr Peichl; Minglong Chen; Narayanan Namboodiri; Luis Aguinaga; Luiz Roberto Leite; Sana M Al-Khatib; Elad Anter; Antonio Berruezo; David J Callans; Mina K Chung; Phillip Cuculich; Andre d'Avila; Barbara J Deal; Paolo Della Bella; Thomas Deneke; Timm-Michael Dickfeld; Claudio Hadid; Haris M Haqqani; G Neal Kay; Rakesh Latchamsetty; Francis Marchlinski; John M Miller; Akihiko Nogami; Akash R Patel; Rajeev Kumar Pathak; Luis C Saenz Morales; Pasquale Santangeli; John L Sapp; Andrea Sarkozy; Kyoko Soejima; William G Stevenson; Usha B Tedrow; Wendy S Tzou; Niraj Varma; Katja Zeppenfeld
Journal:  J Interv Card Electrophysiol       Date:  2020-10       Impact factor: 1.900

3.  Catheter Ablation of Ventricular Tachycardia: Moving Beyond Palliation?

Authors:  Nilesh Mathuria
Journal:  Tex Heart Inst J       Date:  2016-10-01

Review 4.  Catheter Ablation of Ventricular Tachycardia.

Authors:  Nilesh Mathuria
Journal:  Tex Heart Inst J       Date:  2018-06-01

5.  Prognostic Impact of the Timing of Recurrence of Infarct-Related Ventricular Tachycardia After Catheter Ablation.

Authors:  Konstantinos C Siontis; Hyungjin Myra Kim; William G Stevenson; Akira Fujii; Paolo Della Bella; Pasquale Vergara; Kalyanam Shivkumar; Roderick Tung; Duc H Do; Emile G Daoud; Toshimasa Okabe; Katja Zeppenfeld; Marta de Riva Silva; Gerhard Hindricks; Arash Arya; Alexander Weber; Karl-Heinz Kuck; Andreas Metzner; Shibu Mathew; Johannes Riedl; Miki Yokokawa; Krit Jongnarangsin; Rakesh Latchamsetty; Fred Morady; Frank M Bogun
Journal:  Circ Arrhythm Electrophysiol       Date:  2016-12

6.  Selection of the Best of 2016 in Catheter Ablation.

Authors:  David Filgueiras-Rama; Frank Bogun; Nicasio Pérez-Castellano; Fred Morady; José Jalife; Julián Pérez-Villacastín
Journal:  Rev Esp Cardiol (Engl Ed)       Date:  2017-04

7.  2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias.

Authors:  Edmond M Cronin; Frank M Bogun; Philippe Maury; Petr Peichl; Minglong Chen; Narayanan Namboodiri; Luis Aguinaga; Luiz Roberto Leite; Sana M Al-Khatib; Elad Anter; Antonio Berruezo; David J Callans; Mina K Chung; Phillip Cuculich; Andre d'Avila; Barbara J Deal; Paolo Della Bella; Thomas Deneke; Timm-Michael Dickfeld; Claudio Hadid; Haris M Haqqani; G Neal Kay; Rakesh Latchamsetty; Francis Marchlinski; John M Miller; Akihiko Nogami; Akash R Patel; Rajeev Kumar Pathak; Luis C Sáenz Morales; Pasquale Santangeli; John L Sapp; Andrea Sarkozy; Kyoko Soejima; William G Stevenson; Usha B Tedrow; Wendy S Tzou; Niraj Varma; Katja Zeppenfeld
Journal:  Europace       Date:  2019-08-01       Impact factor: 5.214

Review 8.  Ventricular Tachycardia with ICD Shocks: When to Medicate and When to Ablate.

Authors:  Amir AbdelWahab; John Sapp
Journal:  Curr Cardiol Rep       Date:  2017-09-13       Impact factor: 2.931

Review 9.  Update on prevention and treatment of sudden cardiac arrest.

Authors:  Yuliya Krokhaleva; Marmar Vaseghi
Journal:  Trends Cardiovasc Med       Date:  2018-11-06       Impact factor: 6.677

10.  Long-term outcome of ventricular tachycardia ablation in patients who did not undergo programmed electrical stimulation after ablation.

Authors:  Takeshi Kitamura; Seiji Fukamizu; Tomoyuki Arai; Kohei Kawajiri; Sho Tanabe; Sayuri Tokioka; Dai Inagaki; Rintaro Hojo
Journal:  J Interv Card Electrophysiol       Date:  2021-07-28       Impact factor: 1.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.